Cipla Q3 Profit Falls Short of Estimates

Mumbai: Cipla Ltd, India's fifth-largest drug maker, reported third-quarter profit below analysts' expectations.

Cipla, which gets a majority of its sales from India, posted a net profit of Rs 343 crore ($50.58 million) for the quarter ended December 31, slightly above the Rs 328 crore reported a year earlier.

Analysts, on average, had expected a profit of Rs 428 crore.

($1 = Rs 67.82)